Yuhong Lu

1.4k total citations
55 papers, 1.1k citations indexed

About

Yuhong Lu is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Yuhong Lu has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Immunology and 21 papers in Hematology. Recurrent topics in Yuhong Lu's work include CAR-T cell therapy research (22 papers), Immune Cell Function and Interaction (17 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Yuhong Lu is often cited by papers focused on CAR-T cell therapy research (22 papers), Immune Cell Function and Interaction (17 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Yuhong Lu collaborates with scholars based in China, Canada and United States. Yuhong Lu's co-authors include Michaël Pollak, Yangqiu Li, Xiaolin Zi, Shaohua Chen, Ling Xu, Anne Camirand, Lijian Yang, Jiaxiong Tan, Jing Lai and Danlin Yao and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Yuhong Lu

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuhong Lu China 19 572 456 394 282 125 55 1.1k
Dariusz Wołowiec Poland 20 661 1.2× 621 1.4× 401 1.0× 347 1.2× 42 0.3× 81 1.4k
Chirag Acharya United States 14 855 1.5× 344 0.8× 583 1.5× 820 2.9× 263 2.1× 29 1.5k
Yu‐Waye Chu United States 20 774 1.4× 523 1.1× 261 0.7× 227 0.8× 334 2.7× 43 1.2k
K. Papadopoulos United States 16 540 0.9× 299 0.7× 598 1.5× 48 0.2× 121 1.0× 56 1.1k
Obul Reddy Bandapalli Germany 19 401 0.7× 340 0.7× 501 1.3× 319 1.1× 13 0.1× 47 1.3k
Stephen J. Blakemore United States 17 339 0.6× 137 0.3× 969 2.5× 184 0.7× 29 0.2× 47 1.4k
Haifan Zhang United States 18 376 0.7× 165 0.4× 708 1.8× 74 0.3× 447 3.6× 30 1.1k
Nicola Calvani Italy 16 382 0.7× 296 0.6× 325 0.8× 157 0.6× 80 0.6× 46 911
Roger Mouawad France 21 308 0.5× 208 0.5× 523 1.3× 65 0.2× 56 0.4× 57 968
Jan B. Egan United States 16 448 0.8× 89 0.2× 868 2.2× 709 2.5× 66 0.5× 34 1.6k

Countries citing papers authored by Yuhong Lu

Since Specialization
Citations

This map shows the geographic impact of Yuhong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong Lu more than expected).

Fields of papers citing papers by Yuhong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong Lu. The network helps show where Yuhong Lu may publish in the future.

Co-authorship network of co-authors of Yuhong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhong Lu. A scholar is included among the top collaborators of Yuhong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhong Lu. Yuhong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ling, Lian Liu, Danlin Yao, et al.. (2021). PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow. Frontiers in Oncology. 11. 686156–686156. 31 indexed citations
2.
Yao, Danlin, Ling Xu, Jing Lai, et al.. (2020). Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia. BioMed Research International. 2020(1). 9531549–9531549. 14 indexed citations
3.
Tan, Jiaxiong, Jingying Huang, Youchun Chen, et al.. (2020). Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML. Biomarker Research. 8(1). 6–6. 65 indexed citations
4.
Huang, Jingying, Jiaxiong Tan, Youchun Chen, et al.. (2019). A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia. Journal of Leukocyte Biology. 106(3). 725–732. 25 indexed citations
5.
Liu, Chang, Danian Nie, Juan Li, et al.. (2018). Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells. Cancer Research. 78(6). 1522–1536. 26 indexed citations
6.
Zhou, Jingfeng, Danian Nie, Juan Li, et al.. (2017). PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia. Clinical Cancer Research. 24(1). 145–157. 27 indexed citations
7.
Tan, Jiaxiong, Shaohua Chen, Yuhong Lu, et al.. (2017). Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia. Chinese Journal of Cancer Research. 29(5). 463–470. 70 indexed citations
8.
Tan, Jiaxiong, Shaohua Chen, Danlin Yao, et al.. (2017). Higher Tim-3 expression concurrent with PD-1 in exhausted CD4+ and CD8+T cells in patients with acute myeloid leukemia. Experimental Hematology. 53. S84–S85. 3 indexed citations
9.
Jin, Yanli, Danian Nie, Juan Li, et al.. (2016). Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin. Clinical Cancer Research. 23(11). 2842–2855. 37 indexed citations
10.
Lu, Yuhong, et al.. (2016). When and Why EFL Teachers Use L1. International Journal of Learning Teaching and Educational Research. 14(2).
11.
Jin, Yanli, Yiwu Yao, Li Chen, et al.. (2016). Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib. Theranostics. 6(11). 1947–1962. 28 indexed citations
12.
Shi, Li, Shaohua Chen, Xianfeng Zha, et al.. (2015). Enhancement of the TCRζ Expression, Polyclonal Expansion, and Activation of T Cells from Patients with Acute Myeloid Leukemia After IL-2, IL-7, and IL-12 Induction. DNA and Cell Biology. 34(7). 481–488. 11 indexed citations
13.
He, Zheng, Yun Sun, Yuhong Lu, et al.. (2015). Efficacy and Safety of Supramaximal Titrated Inhibition of Renin-Angiotensin-Aldosterone System in Idiopathic Dilated Cardiomyopathy. ESC Heart Failure. 2(4). 129–138. 12 indexed citations
14.
Xu, Ling, Yuhong Lu, Jing Lai, et al.. (2015). Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations. Science China Life Sciences. 58(12). 1276–1281. 11 indexed citations
15.
Zeng, Chengwu, Yuhong Lu, Shaohua Chen, et al.. (2014). A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway. Cancer Cell International. 14(1). 137–137. 15 indexed citations
16.
Shen, Qi, Sichu Liu, Yu Chen, et al.. (2013). Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation. Journal of Hematology & Oncology. 6(1). 64–64. 17 indexed citations
17.
Shi, Li, Shaohua Chen, Yuhong Lu, et al.. (2013). Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML. Cancer Cell International. 13(1). 37–37. 15 indexed citations
18.
Zha, Xianfeng, Shaohua Chen, Lijian Yang, et al.. (2012). Upregulated TCRζ Enhances Interleukin-2 Production in T-Cells from Patients with CML. DNA and Cell Biology. 31(11). 1628–1635. 12 indexed citations
19.
Lu, Yuhong, Xiaolin Zi, Yunhua Zhao, & Michaël Pollak. (2003). Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc–MAPK signaling pathway in breast cancer cells. Biochemical and Biophysical Research Communications. 313(3). 709–715. 28 indexed citations
20.
Camirand, Anne, Yuhong Lu, & Michaël Pollak. (2002). Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells.. PubMed. 8(12). BR521–6. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dariusz Wołowiec Breakdown of academic impact, for papers by Chirag Acharya Breakdown of academic impact, for papers by Yu‐Waye Chu Breakdown of academic impact, for papers by K. Papadopoulos Breakdown of academic impact, for papers by Obul Reddy Bandapalli Breakdown of academic impact, for papers by Stephen J. Blakemore Breakdown of academic impact, for papers by Haifan Zhang Breakdown of academic impact, for papers by Nicola Calvani Breakdown of academic impact, for papers by Roger Mouawad Breakdown of academic impact, for papers by Jan B. Egan
Rankless by CCL
2026